Related Experiment Videos
Alkylating properties of dichlorvos (DDVP)
Acta Pharmacologica Et Toxicologica
|January 1, 1981
Summary
Dichlorvos (DDVP) is a methylating agent that showed low genetic risk in mice DNA studies. However, its mutagenic effectiveness requires further evaluation, especially concerning its metabolite dichloroacetaldehyde.
Area of Science:
- Toxicology
- Genetics
- Environmental Health
Background:
- Dichlorvos (DDVP) is an organophosphate insecticide known to be a methylating agent.
- Understanding the genotoxic potential of DDVP is crucial for human health risk assessment.
Purpose of the Study:
- To quantify the DNA alkylation by DDVP in vivo.
- To estimate the clearance rate of DDVP from DNA.
- To assess the genetic risk associated with DDVP exposure in humans.
Main Methods:
- Administration of DDVP to mice at a specific dose (1.9 x 10(-6) mol/kg).
- Quantification of guanine-N-7 alkylation in mouse DNA.
- Estimation of DDVP clearance rate based on DNA adduct levels.
- Comparison of DDVP's mutagenic effectiveness with methyl methanesulfonate.
Main Results:
- A specific level of guanine-N-7 alkylation (8 x 10(-13) mol methyl per g DNA) was detected in mice exposed to DDVP.
- An estimated clearance rate of 29 hr-1 was derived from the DNA alkylation data.
- This clearance rate aligns with previously published data on DDVP brain concentrations.
- The genetic risk to humans from DDVP's methylating activity was assessed as low to very low.
- DDVP demonstrated higher mutagenic effectiveness than predicted by kinetic data.
Conclusions:
- The direct methylating activity of DDVP poses a low genetic risk.
- DDVP's in vivo mutagenic effectiveness may be underestimated by reaction kinetics alone.
- Further investigation into the role of dichloroacetaldehyde, a DDVP metabolite, is necessary for a comprehensive risk assessment.